Evaluating the influence MRSA Co-infection on 28-day mortality among sepsis patients: insights from the MIMIC-IV database
While MRSA co-infection's direct impact on 28-day sepsis mortality is minimal, antimicrobial sensitivity, especially to cephalosporins, meropenem, and piperacillin/tazobactam, plays a critical role in improving outcomes, underscoring the importance of antimicrobial stewardship and personalized treatment strategies in sepsis care.
Authors
- Miao Yan (ORCID: https://orcid.org/0000-0003-3742-1557)
- Bikui Zhang (ORCID: https://orcid.org/0000-0001-7148-7926)
- Zhihua Sun (ORCID: https://orcid.org/0000-0003-2659-3927)
- Yi‐Chang Zhao (ORCID: https://orcid.org/0000-0002-9651-4457)
- Yukun Zhang (ORCID: https://orcid.org/0000-0003-4487-9988)
- Rao Fu (ORCID: https://orcid.org/0000-0001-9800-9457)
- Jia-Kai Li
Institutions
- Central South University (CN)
- China Pharmaceutical University (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-11
- DOI
- https://doi.org/10.3389/fphar.2025.1534107
- Citations
- 2
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 2.79